7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Ocuphire Pharma Inc
(NASDAQ:OCUP) 

OCUP stock logo

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan.

Founded: 2018
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends
Ocuphire Pharma Number of Twitter Followers
202305 202306 202307 202308 202309 202310 018.7137.4356.1474.8693.57112.29131
Ocuphire Pharma Days Payable Outstanding ttm (DPO)
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 024.6449.2773.9198.55123.19147.82172.46Thousand
Ocuphire Pharma Days Receivable Outstanding ttm (DSO)
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 010.3420.6831.0241.3551.6962.0372.37
Ocuphire Pharma Days Inventory Outstanding ttm (DIO)
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 05.6411.2916.9322.5828.2233.8739.51Thousand
Ocuphire Pharma Op Cashflow Per Share ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.050.110.270.430.60.760.921.08
Ocuphire Pharma Free Cashflow Per Share ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.050.110.270.430.60.760.921.08
Ocuphire Pharma Cash Per Share ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.310.630.941.261.571.882.2
Ocuphire Pharma P/S ratio ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.360.711.071.421.782.132.49
Ocuphire Pharma (GAAP) P/E ratio ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.55-3.22-1.89-0.550.782.113.454.78
Ocuphire Pharma P/B ratio ttm
202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.320.630.951.261.581.892.21
No extra charts and metrics for this ticker.